Introduction
Despite the variety of toxicity testing methods now available, vexing uncertainties persist in estimating the risk to humans posed by environmental contaminants. Major problems arise in extrapolating test results among species, from high to low doses, and to chemical mixtures. Advances in dealing with these uncertainties are anticipated to result from better mechanistic understanding of the interactions of agents with target cells. In turn, as differentiated functions of target cells become better understood, the actions of toxic agents will be more readily elucidated. An added incentive to examining the perturbation of cellular processes is that such study is likely to provide further insight into normal regulatory and developmental phenomena, some of which are poorly understood at present. Inasmuch as they are common targets of environmental agents, keratinocytes are especially appropriate for this type of investigation. Considerable information has accumulated on the differentiated functions of this cell type (1) , which can now be serially cultivated from humans and various animal species. Among the useful markers of keratinocyte maturation available for study (including filaggrin and the keratin intermediate filament proteins) are involucrin and keratinocyte transglutaminase. The latter is a membrane-bound enzyme responsible for cross-linking involucrin (2, 3) and certain other proteins (4, 5) into insoluble cornified envelope structures (6, 7) . Involucrin is found throughout the primate order (8) but has been difficult to identify in other aniimals, although evidence has been reported recently for a related protein in bovine epidermis (9) . Keratinocyte transglutaminase is distinct from the tissue transglutaminase found in many cell types in its regulation and its biochemical and immunochemical properties (7, 10, 11) . The relationships of these enzymes to the soluble transglutaminases purified from epidermis and hair follicle are uncertain (12) (13) (14) .
One approach to investigating toxic mechanisms in culture has been to examine directly the neoplastic response of keratinocytes to tumor initiators, promoters, and oncogenes (15) , in some cases treating the animal skin before cultivation (16) . This work often exploits the sensitivity of normal but not transformed murine cells to high calcium medium, where they terrninally differentiate (17) .
Both normal and malignant human keratinocytes express xenobiotic metabolism (e.g., aryl hydrocarbon hydroxylase) in culture and consequently are sensitive to DNA damage and the mutagenic action of polycyclic aromatic hydrocarbons and related agents. Applicability of these cells to investigating mechanisms of mutagenesis and to screening of unknowns for mutagenic potency has been described (18) .
A second approach to studying toxic mechanisms has been to examine the physiological modulation of keratinocyte differentiation and its disturbance by model agents. Acquisition of malignancy is generally a multistep process that can be set in motion by genetic damage, although alteration of developmental or other processes not clearly involving DNA damage can be important (19) . Rare genetic events often appear to be rate limiting, but recent evidence points to a role for common cellular events in carcinogen-treated populations in enhancing the incidence or detection of malignant change (20, 21) . Moreover, the desirability of testing for chronic toxicity other than carcinogenesis is evident. Interference of model agents in the regulation of cellular processes or responses to signals from their microenvironment may be diagnostic for a variety of syndromes, possibly even at target sites other than stratified squamous epithelia.
For example, in view of their responsiveness to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (22) , as well as to a number of endogenous effectors of differentiation, keratinocytes (including cell lines derived from neoplasias) provide a useful model in which to study the action of this agent. Pursuant to previous indications that the toxic action of TCDD may result from its interference with normal hormone action (23) , a number of studies have now reported examples of this phenomenon (24) . Malignant human keratinocytes appear defective in their ability to differentiate terminally (25) . However, they can exhibit at confluence a moderately high level of keratinocyte transglutaminase, which is expressed in normal epidermis in the upper spinous layer (7), and a high keratin content. Hydrocortisone in the culture medium stimulates these markers 4-to 6-fold in the SCC-13 cell line. TCDD has little effect on their expression in the absence of added glucocorticoid, but it largely antagonizes the action of hydrocortisone when the cells are grown in the presence of both agents (26) .
In contrast to SCC-13, the SCC-4 cell line shows relatively little keratinocyte character but does exhibit great sensitivity to vitamin A in induction of tissue transglutaminase to high levels (11 
Results

12-O-Tetradecanoylphorbol-13-Acetate
Cell lines derived from epidermal squamous carcinomas are generally insensitive to the toxic effects of 12-0-tetradecanoylphorbol-13-acetate (TPA) compared to normal epidermal cells (34, 35) , as shown for SCC-13 in Figure 1 . A special case is the human epidermal line SCC-12F2, im-SCC-13_ SCC-1 2F2:.~1l TA (nM) 0.01 mortal but not malignant (27) , which is reduced in colonyforming efficiency by this agent (34 (38, 39) . Thus, the present work has concentrated specifically on expression of the known markers transglutaminase and involucrin. Cultures treated chronically with TPA were examined for their expression of these keratinocyte differentiation markers, as shown in Figure 3 . The cells were harvested 5 to 6 days after confluence, when the markers in parallel control cultures were at maximal values. Measurements made 2 to 3 weeks after confluence gave similar results, although the control values were considerably lower, as indicated in Figure 2 . Cultures treated with 1 nM TPA showed a small elevation in the specific activity of both markers, while those treated with higher concentrations showed substantial reductions. The involucrin content, more sensitive than transglutaminase activity, was reduced to less than 10% of the control value at 1 AM TPA.
Polycyclic Aromatic Hydrocarbon ¶bxicity
Epithelial cells from a variety of rat tissues are cultivable with 3T3 feeder layer support (28, 29) . A survey of their sensitivities to inhibition of growth by 3-methyl- cholanthrene (3-MC) has shown striking differences, as summarized in Table 1 . This agent produced its most powerful effect in rat epidermal and mammary epithelial cells, with a concentration dependence similar to that observed previously for epidermal cells (40) , whereas bladder, prostate, thyroid, and endometrial cells, for example, were insensitive. The basis for this difference in response remains to be elucidated. That the sensitive cells responded only to a small extent to TCDD compared to 3-MC in the medium, as shown in Figure 4 , indicates that the production of metabolites was important and not simply activation of whatever genes are under the control of the Ah receptor. The action of neither TCDD nor 3-MC on the epidermal cells was altered by omission of epidermal growth factor from the medium (S. E. Crane and R. H. Rice, unpublished), indicating that inhibition of growth could not be ascribed primarily to the loss of receptors for this polypeptide that occurs in human epidermal and certain keratinocyte lines (41, 42) . Although rat epidermal cells are highly sensitive to 3-MC in early passage, we have previously found that upon continued propagation both sensitivity and expression of aryl hydrocarbon hydroxylase activity are lost, suggesting the latter is necessary for the evident toxicity. However, similar to previous findings, the capacities to metabolize polycyclic aromatic hydrocarbons were comparable in the cell types examined (epidermal, esophageal, forestomach, vaginal, mammary). Such Its action takes approximately 6 hr for maximal effect ( Figure 5 , right panel) and is prevented by cycloheximide, indicative of a requirement for protein synthesis (32) . Physiological agents raising intracellular cAMP, including follicle-stimulating hormone and prostaglandins E 1 or E2, are known to be effective in modulating functions of estrogen responsive cells of the female genital tract (46) . In a search for endogenous effectors that might be of physiological relevance, cultures were treated with crude preparations of several peptide hormones obtained from the National Hormone and Pituitary Program. Standard preparations of ovine (follicle stimulating hormone), porcine (follicle stimulating hormone, leutinizing hormone), and rat (growth hormone, prolactin, hypothalamic extract) origin employed under various conditions did not materially alter the receptor level. In some experiments, treatment of the cultures with prostaglandins E1 or E2 led to a 2-to 3-fold increase in receptor level over a 4 to 6 hr time period (prostaglandins B1, '2 and F2Z were virtually inactive), but this finding was not readily reproducible, perhaps due to variable endogenous prostaglandin production by the epithelial or the few remaining 3T3 cells. 
Discussion
Treatment of cultured keratinocytes from normal mouse or human epidermis with TPA induces a state resembling terminal differentiation in a majority of the cells, although a substantial fraction of transiently resistant cells is evident corresponding to the germinative population (34, 35, 41 Upon chronic treatment of SCC-12F2 (and SCC-9) cultures, the TPA concentration dependence shows that involucrin is considerably more sensitive to suppression than transglutaminase. Whether this phenomenon represents an effect on transcription remains to be seen. The keratinocyte transglutaminase is subject to phosphorylation, which is stimulable 5-fold by treatment of cultured normal epidermal cells for several hours with TPA (R. Chakravarty and R. H. Rice, unpublished) . Thus, posttranslational modification(s) could account for some alteration in measured activity. Moreover, involucrin is quite sensitive to proteolytic degradation and could be subject to rapid depletion as a consequence of protease activation. Indeed, protein kinase C is dramatically depleted in a variety of cell types, including A431 malignant human keratinocytes (48) , as well as in mouse skin (49) , perhaps due to enhanced proteolysis (50) . The possibility that TPAmediated production of reactive oxygen species (51, 52) may contribute to this differentiation suppression has not been ruled out, however. If protein kinase C ordinarily mediates keratinocyte differentiation, suggested by its observed stimulation of differentiated properties in cultured normal keratinocytes, then its depletion could be responsible for the suppressive effect in these chronically treated cells. Regardless of this hypothesis, a biphasic growth inhibition response induced by TPA as in SCC-12F2 has been reported in a number of cell types (53) . In some cases (such as this), perhaps a drastic depletion of protein kinase C at the highest concentrations of TPA employed could release the cells from a growth inhibitory influence of the kinase activity present at lower concentrations.
Although keratinocytes from various anatomic sites have much in common, they retain and under appropriate circumstances display intrinsic differences in their differentiation program (54) , perhaps arising in part as a consequence of their developmental pathways. In addition to pharmacokinetic factors, these differences are likely to result in distinctive responses to physiological and pathological conditions. The striking contrast in the response of cultured rat epithelial cells to the polycyclic aromatic hydrocarbon 3-MC suggests these intrinsic differences could have major influences on carcinogen target specificity, for example. It is not clear at present how relative toxicity (growth inhibition) may relate to carcinogenicity in this instance. One possibility, similar to the selection scheme proposed for preneoplastic lesions of the rat liver (55) , is that epidermal cells metabolizing the agent are prevented from growing. Those variants arising which lack such metabolic capability may then be selectively provided with the opportunity to replace the normal cells. Variants lacking aryl hydrocarbon hydroxylase that are not sensitive to 3-MC toxicity do arise in epidermal cell populations even without 3-MC treatment upon continued passage (28) . Alternately, one could imagine that continued carcinogen metabolism by the esophageal cells without toxicity might permit a greater burden of DNA (59) , squamous metaplasia. In any case, the culture phenotype appears to approximate behavior within the cellular repertoire in vivo under conditions of stress (hormonal imbalance, vitamin deprivation, physical trauma, neoplastic influence). Squamous metaplasia is inducible even in the rodent mammary epithelium (60) and is seen in human mammary tissue (61) . New biochemical properties may well influence the target susceptibility of these cells to exogenous agents or alter the ensuing pathology. Loss of characteristic specialized function may be only partial, with enough remaining to permit study of important normal processes. Thus, the responsiveness of estrogen receptor content in the rat endometrial cells to agents elevating intracellular cAMP suggests possible usefulness in studying the mechanism of this phenomenon and consequences of its disturbance. Enhanced estrogen responsiveness of the cells by cAMP elevation may merit exploration, especially in conjunction with alterations in the growth substratum that have permitted maintenance of normal function in cultured mammary and tracheal epithelial cells (62, 63) . In addition, since the adenyl cyclase/phosphodiesterase pathway is sensitive to perturbation by exogenous agents, the cells may provide a suitable model for examining certain types of reproductive toxicity.
As these results demonstrate, epithelial cell culture models can be instrumental in elucidating physiological and biochemical bases for differences in regulation and response among tissue types and species. Further investigations in these directions, in conjunction with in vivo observations, could ultimately aid in prediction of human responses to new or uncharacterized toxic substances.
